TNSN96109A1 - ZWITTERIONIC FORMS OF TROVAFLOXACIN, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM - Google Patents

ZWITTERIONIC FORMS OF TROVAFLOXACIN, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM

Info

Publication number
TNSN96109A1
TNSN96109A1 TNTNSN96109A TNSN96109A TNSN96109A1 TN SN96109 A1 TNSN96109 A1 TN SN96109A1 TN TNSN96109 A TNTNSN96109 A TN TNSN96109A TN SN96109 A TNSN96109 A TN SN96109A TN SN96109 A1 TNSN96109 A1 TN SN96109A1
Authority
TN
Tunisia
Prior art keywords
trovafloxacin
preparation
compositions containing
zwitterionic forms
crystalline
Prior art date
Application number
TNTNSN96109A
Other languages
French (fr)
Inventor
John Meldrum Allen Douglas
Bruning Joseph David
Norris Timothy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN96109A1 publication Critical patent/TNSN96109A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)

Abstract

L'INVENTION CONCERNE UNE FORME ZWITTERIONIQUE DE TROVAFLOXACINE DE FROMULE I :CHOISIE ENTRE SA FORME POLYMORPHE HYGROSCOPIQUE CRISTALLINE DE SA FORME POLYMORPHE NON HYGROSCOPIQUE CRISTALLINE ET SON PENTAHYDRATE CRISTALLIN. ELLE CONCERNE EGALEMENT DES PROCEDES POUR SA PREPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LA CONTENANT. APPLICATION : UTILISATION POUR LE TRAITEMENT D'INFECTIONS BACTERIENNES CHEZ DES MAMMIFERES.THE INVENTION RELATES TO A ZWITTERIONIC FORM OF CHEESE TROVAFLOXACIN I: SELECTED BETWEEN ITS CRYSTALLINE HYGROSCOPIC POLYMORPHIC FORM OF ITS CRYSTALLINE NON-HYGROSCOPIC POLYMORPHIC FORM AND ITS CRYSTALLINE PENTAHYDRATE. IT ALSO CONCERNS PROCESSES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. APPLICATION: USE FOR THE TREATMENT OF BACTERIAL INFECTIONS IN MAMMALS.

TNTNSN96109A 1995-08-29 1996-08-28 ZWITTERIONIC FORMS OF TROVAFLOXACIN, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM TNSN96109A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
TNSN96109A1 true TNSN96109A1 (en) 2005-03-15

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96109A TNSN96109A1 (en) 1995-08-29 1996-08-28 ZWITTERIONIC FORMS OF TROVAFLOXACIN, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM

Country Status (30)

Country Link
EP (1) EP0850060A1 (en)
JP (1) JP3188476B2 (en)
KR (1) KR100343909B1 (en)
CN (1) CN1190889A (en)
AP (1) AP636A (en)
AR (1) AR003985A1 (en)
AU (1) AU704115B2 (en)
BR (1) BR9609998A (en)
CA (1) CA2229786C (en)
CO (1) CO4480739A1 (en)
CZ (1) CZ56698A3 (en)
DZ (1) DZ2087A1 (en)
GT (1) GT199600072A (en)
HR (1) HRP960395B1 (en)
HU (1) HUP9900170A3 (en)
IL (1) IL122651A (en)
MA (1) MA23966A1 (en)
MY (1) MY113874A (en)
NO (1) NO309814B1 (en)
NZ (1) NZ312199A (en)
OA (1) OA10669A (en)
PE (1) PE12598A1 (en)
PL (1) PL325170A1 (en)
RU (1) RU2144921C1 (en)
SK (1) SK23898A3 (en)
TN (1) TNSN96109A1 (en)
TR (1) TR199800339T1 (en)
WO (1) WO1997007800A1 (en)
YU (1) YU48396A (en)
ZA (1) ZA967282B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (en) 1997-08-01 1999-01-08 Pfizer Prod Inc PARENTERAL COMPOSITIONS OF ALATROFLAXACINO
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (en) * 1998-01-21 2000-09-29 Pfizer Prod Inc TROVAFLOXACINO MESYLATE TABLET
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (en) * 1998-09-03 2000-06-19 Pfizer Prod Inc PROCEDURE FOR PREPARING SALTS OF TROVAFLOXACIN FOR ADDITION OF ACIDS.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
IL122651A0 (en) 1998-08-16
DZ2087A1 (en) 2002-07-22
AP636A (en) 1998-04-09
JP3188476B2 (en) 2001-07-16
SK23898A3 (en) 1999-05-07
KR100343909B1 (en) 2003-04-10
CA2229786C (en) 2002-02-19
HUP9900170A2 (en) 1999-05-28
HRP960395A2 (en) 1998-06-30
IL122651A (en) 2000-02-17
RU2144921C1 (en) 2000-01-27
NZ312199A (en) 1999-06-29
AU704115B2 (en) 1999-04-15
TR199800339T1 (en) 1998-06-22
AR003985A1 (en) 1998-09-30
MX9801664A (en) 1998-08-30
HRP960395B1 (en) 2001-12-31
PE12598A1 (en) 1998-03-20
CO4480739A1 (en) 1997-07-09
CZ56698A3 (en) 1999-02-17
AU6367696A (en) 1997-03-19
GT199600072A (en) 1998-02-14
MA23966A1 (en) 1997-04-01
BR9609998A (en) 1999-07-06
OA10669A (en) 2000-11-06
EP0850060A1 (en) 1998-07-01
KR19990044232A (en) 1999-06-25
AP9600853A0 (en) 1996-10-31
ZA967282B (en) 1998-03-02
NO980862D0 (en) 1998-02-27
YU48396A (en) 1998-12-23
WO1997007800A1 (en) 1997-03-06
MY113874A (en) 2002-06-29
NO980862L (en) 1998-02-27
NO309814B1 (en) 2001-04-02
JPH10511692A (en) 1998-11-10
CA2229786A1 (en) 1997-03-06
CN1190889A (en) 1998-08-19
PL325170A1 (en) 1998-07-06
HUP9900170A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
TNSN99214A1 (en) NOVEL AZALIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN98150A1 (en) DERIVATIVES OF ARYLOXYARYLSULFONYLAMINOHYDROXAMIC ACIDS; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98182A1 (en) NOVEL PROSTAGLANDIN AGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98019A1 (en) ARYLSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN99073A1 (en) NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98194A1 (en) NOVEL 6-O-METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98025A1 (en) ARYLSULFONYLHYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
TNSN98022A1 (en) N-HYDROXY-β-SULFONYLPROPIONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN99156A1 (en) NOVEL HYDROXYPIPECOLATE-HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98112A1 (en) DIPEPTIDE COMPOUNDS
TNSN99171A1 (en) 4-CARBOXYAMINO-2-SUBSTITUE-1,2,3,4-TETRAHYDROQUINOLEINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98238A1 (en) NEW MACROLIDES
TNSN96172A1 (en) HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN99170A1 (en) NOVEL SUBSTITUTED TETRAHYDROQUINOLEIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN01017A1 (en) COMPOSITIONS COMPRISING AN AZALIDE ANTIBIOTIC, AND METHODS FOR THEIR PREPARATION
TNSN99169A1 (en) NOVEL 4,4-BIARYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99110A1 (en) NON-PEPTIDE INHIBITORS OF VLA-4 DEPENDENT CELL ADHESION, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN01167A1 (en) ACID AMIDE SALT FORMS 3- (4-BROMO-2,6-DIFLUORO-BENZYLOXY) - 5 [3 - (4 - PYRROLIDINE - 1 - YL - BUTYL) UREIDO] ISOTHIAZOLE - 4 - CARBOXYLIC, AND PROCESS FOR THEIR PRODUCTION.
TNSN98083A1 (en) 6-0 METHYLERYTHROMYCIN A DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN98066A1 (en) TETRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN96104A1 (en) (1S, 2S) -1- (4-HYDROXYPHENYL) -2- (4-HYDROXY-4-PHENYLPIPERIDINE-1-YL) -1-PROPANOL TRIHYDRATE METAHENSULFONATE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
FR2780403B3 (en) NOVEL FORM OF IRBESARTAN, METHODS FOR OBTAINING SAID FORM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
TNSN98127A1 (en) AZETIDINYLPROPYLPIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN00231A1 (en) CRYSTALLINE FORM OF 4-CARBOXYAMINO-2-SUBSTITUE-1,2,3,4- TETRAHYDROQUINOLEINE, AND COMPOSITIONS CONTAINING IT
TNSN98024A1 (en) 2-AMINO-6- (2-SUBSTITUE-4-PHENOXY) -SUBSTITUE-PYRIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.